Hospitals to put doctors' relationships with pharmaceutical companies under the microscope
The University of Colorado School of Medicine, National Jewish and Denver Health are all reviewing and tightening ethics rules as dozens of doctors defy reporting requirements for drug-company payments that can reach well into six figures.
National Jewish, most of whose doctors have dual roles with CU, said it is conducting its own rules review after a preliminary CU report said doctors were testing ethical boundaries and ignoring or disobeying disclosure rules.
"The status quo is no longer acceptable," said Richard Krugman, dean of the CU medical school.
Denver Health spokeswoman Dee Martinez said the hospital system is also reviewing its ethics policies for potential revision, given the recent outcry about pharmaceutical- company spending.
- The Secret to Physician Engagement? It's Not Better Pay
- Don't Underestimate Emotional Intelligence
- Two-Midnight Rule Must be Fixed or Replaced, Say Providers
- Yale New Haven Health Partners with Tenet Healthcare in CT
- Care Coordination Tough to Define, Measure
- Size Matters in Antibiotic Overuse
- 4 Reasons PCMH Principles Aren't Going Away
- CDC Warns of Antibiotic Overuse in Hospitals
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- SCOTUS Review of NC Board Case 'A Very Big Deal' to Providers